Related Experiment Video
Updated: Sep 30, 2026

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
Published on: September 11, 2020
Streptococcus pneumoniae bacteraemia in Belgium: differential characteristics in children and the elderly population
J Flamaing1, J Verhaegen, W E Peetermans
1Department of Geriatric Medicine, Department of Microbiology, Department of General Internal Medicine, University Hospital Leuven, Leuven, Belgium.
Insights
Invasive Streptococcus pneumoniae bloodstream infections (bacteraemia) are common in children and the elderly. Antibiotic resistance is rising in both groups, with children showing higher erythromycin resistance, and vaccine strategies need to consider these trends.
Area of Science:
- * Infectious Diseases
- * Microbiology
- * Pediatrics and Geriatrics
Background:
- * Streptococcus pneumoniae is a leading cause of bacterial infections worldwide.
- * Bacteraemia, a serious bloodstream infection, requires understanding of epidemiological trends and resistance patterns.
- * Vulnerable populations, including young children and the elderly, are at higher risk for invasive pneumococcal disease.
Purpose of the Study:
- * To compare the characteristics of Streptococcus pneumoniae bacteraemia in children (0-4 years) and the elderly (>=60 years).
- * To analyze trends in antibiotic resistance and serotype distribution over a 7-year period (1994-2000).
- * To evaluate the potential impact of current and future pneumococcal vaccines in these age groups.
Main Methods:
- * Retrospective analysis of 5837 blood isolates of invasive Streptococcus pneumoniae.
- * Comparison of data from children (n=843) and the elderly (n=3144) from 1994-2000.
- * Assessment of penicillin and erythromycin resistance, serogroup and serotype (SGTs) distribution, and vaccine coverage.
Main Results:
- * Penicillin resistance increased significantly in both children (8.2% to 18.9%) and the elderly (5.1% to 16.35%).
- * Erythromycin resistance was higher in children (44.7%) than the elderly (25.7%) and increased in the elderly (18.6% to 33.65%).
- * The elderly had a broader range of SGTs (36) compared to children (26), with distinct prevalent SGTs in each group. Conjugate vaccines showed higher coverage in children, while the 23-valent vaccine offered broad coverage in the elderly.
Conclusions:
- * Rising antibiotic resistance in Streptococcus pneumoniae necessitates ongoing surveillance and updated treatment guidelines.
- * Distinct serotype prevalence in children and the elderly highlights the need for age-specific vaccination strategies.
- * A combined vaccination approach, utilizing both conjugate and polysaccharide vaccines, may be optimal for comprehensive protection in the elderly.
Abstract:
The characteristics of bacteraemia with Streptococcus pneumoniae in children (0-4 years) and the elderly (> or =60 years) were compared over a 7 year period (1994-2000). Of a total of 7927 isolates of invasive S. pneumoniae studied in the national reference laboratory, 74% (n = 5837) were blood isolates. Of these 5837 S. pneumoniae bacteraemias, 843 (14%) occurred in children and 3144 (54%) in the elderly. The prevalence of penicillin resistance (MIC > or = 0.1 mg/L) in bacteraemic isolates rose from 8.2% to 18.9% (P = 0.03) in children and from 5.1% to 16.35% (P = 0.001) in the elderly over the study period. The prevalence of erythromycin resistance (MIC > or= 1 mg/L) in bacteraemic isolates was significantly higher in children than in the elderly (44.7% versus 25.7%, P = 0.001) and rose significantly over the 7 year period in the elderly (18.6-33.65%, P = 0.001). There were more serogroups and serotypes (SGTs) among the bacteraemic isolates obtained from the elderly compared with children (36 versus 26, P = 0.03). SGTs 6, 14, 18 and 19 cause significantly more bacteraemia in children than in the elderly. The opposite is true for SGTs 3, 7, 8, 9, 11, 12, 15, 20, 22 and 35. The new 7, 9 and 11 valent conjugate vaccine formulations cover significantly more bacteraemic SGTs in children than in the elderly (82%, 89.5% and 92% versus 55.5%, 65% and 77.5%, respectively; P = 0.001). The 23 valent polysaccharide vaccine provides a theoretical coverage of 95% in the elderly population. Our data indicate consideration of a vaccination strategy in the elderly population that combines the efficacy of conjugate vaccines with the broad coverage of the 23 valent polysaccharide vaccine.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Bacterial Meningitis I: Introduction
Pneumonia III: Complications and Assessment
Atypical Pneumonia
Bacterial Meningitis II: Pathophysiology